Concepedia

O-108 Randomized phase III trial of chemotherapy and antisense oligonucleotide LY900003 (ISIS 3521) in patients with advanced NSCLC

Thomas J. Lynch, R. Raju, M. Lind, Aart Brutel de la Rivière, U. Gatzemeier, Andrew Dorr, Jon Holmlund, Anthony P.W. Yuen, Branimir I. Šikić

Lung Cancer · 2003 · 54 citations · 0 references

Concepts

MedicineOncologyPharmacologyChemotherapyMolecular OncologyOncology PharmacotherapyCytotoxic ChemotherapyAntisense RnasOligonucleotide TherapeuticsPhase Iii Oncology Trials